|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Role of liver transplantation in the management of hepatoblastoma in the pediatric population显示文摘Hepatoblastoma(HB) is the most common primary liver tumor in children and accounts for two-thirds of all malignant liver neoplasms in the pediatric population. For patients with advanced HB(unresectable or unresponsive to chemotherapy), combined treatment with chemotherapy and liver transplantation is an excellent option. The etiology of HB is mostly obscure because of its extreme rarity although some inherited syndromes and very low birth weight have been associated with it. The prognosis for children with HB has significantly improved in the past three decades thanks to advancements in chemotherapy, surgical resection and postoperative care. In 2002 a surgical staging system called pretreatment extent of disease(PRETEXT) was designed to allow a universal, multidisciplinary approach to patients with HB. Between one-third to two-thirds of patients initially present with unresectable tumors or distant metastases, but up to 85% of these tumors become operable after neoadjuvant chemotherapy. Patients with PRETEXT categories 1, 2, and some 3 are referred for neoadjuvant chemotherapy followed by surgical resection with the goal of complete tumor removal. Classic treatments regimens include a combination of cisplatin, fluorouracil, and vincristine or cisplatin and doxorubicin. Liver transplantation is the only treatment option for unresectable HB. In 2010 the pediatric end-stage liver disease, a pediatric-specific scoring system that determines a patient's ranking on the liver transplant list, began to award additional 'exception' points for patients with HB. We analyzed the Standard Transplant Analysis and Research dataset to assess the impact of changes in exception point criteria for HB on outcomes after liver transplantation at Texas Children's Hospital in Houston, Texas. We found that patients who were listed for transplantation with current HB exception criteria experienced a shorter waitlist time but survival was similar between the two eras. | Saira Khaderi Jacfranz Guiteau Ronald T Cotton Christine O'Mahony Abbas Rana John A Goss | 2014 | World Journal of Transplantation2014，4，4： | 23 |
| 2 | 24h动态血压监测预测和评估经皮经导管射频消融去肾交感神经术的降压作用显示文摘经皮经导管射频消融去肾交感神经术治疗难治性高血压(renal denervation for resistant hypertension,DENERHTN)临床试验显示,明确诊断的难治性高血压患者经英国指南推荐的标准化阶梯降压治疗(standardized stepped-care antihypertensive treatment,SSAHT)加上使用Symplicity导管的经皮经导管射频消融去肾交感神经术(renal denervation,RDN)。 | Gosse P Cremer A Pereira H Bobrie G Chatellier G Chamontin B Courand P Delsart P Denolle T Dourmap C 练桂丽 叶鹏 | 2017 | 中华高血压杂志2017，25，4： | 6 |
| 3 | Threat Perception in Product Harm Crises:Do Older Consumers Feel More Vulnerable?显示文摘 | Silvera D H Meyer T Laufer D Goss R J Arsena A R | 2010 | Advances in Consumer Research2010，37，： | 1 |
| 4 | Vascular endothelial growth factor gene expression in human fetal lung in vitro显示文摘 | Acarregui M J Penisten S T Goss K L | 1999 | Am J Respir Cell Mol Biol1999，，20： | 1 |
| 5 | Kinetic study of the UO2/C interaction by high-temperature mass spectrometry显示文摘 | Gosse S Gueneau C Alpettaz T | | 0，，238： | 1 |
| 6 | Transcriptionalprofiles of intestinal tumors in Apc(Min)mice are uniquefrom those of embryonic intestine and identify novel gene tar-gets dysregulated in human colorectal tumors显示文摘 | Reichling T Goss KH Carson DJ | 2005 | CancerResearch2005，65，1： | 1 |
| 7 | Double disruptions of the superior shoulder suspensory complex显示文摘 | Goss T P | | 0，，02： | 1 |
| 8 | The reinvention roller coaster:Risking the present for a powerful future显示文摘 | Pascale R Goss T | 1993 | Harvard Business Review1993，71，6： | 1 |
| 9 | Effects of steroidal and nonsteroidal aromatase inhibitors on markers of bone turnover and lipid metabolism in healthy volunteers 显示文摘 | Goss PE Thomsen T Banke-Bochita J | 2003 | Breast Cancer Res Trea2003，82，1： | 1 |
| 10 | Randomized phase Ⅲ trial of gemcitabine compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer显示文摘 | Muteh D G Orlando M Goss T | 2007 | J Clin Oneol2007，25，19： | 1 |
| 11 | Activin receptor-like kinase 1 modulates transforming growth factorβ 1 signaling in the regulation of angiogenesis 显示文摘 | OH P SEKI T GOSS KA | 2000 | Proc Natl Acad SciUSA2000，97，： | 1 |
| 12 | Randomized phase Ⅲ trial of gemcitabine compared with pegylated liposomal doxoru- bicin in patients with platinum - resistant ovarian cancer 显示文摘 | MUTCH D G ORLANDO M GOSS T | 2007 | J Clin Oncol2007，25，19： | 1 |
| 13 | Sorption ofNonionichydrophobic Organic Chemicals to Mineral Surfaces显示文摘 | MADER B T GOSS K U EISENREICH S J | 1997 | Environmental Science & Technology1997，31，4： | 1 |
| 14 | Double disruptions of the superior shoulder suspensory complex显示文摘 | GOSS T P | 1993 | J Orthop Trauma1993，7，： | 1 |
| 15 | Severe odontongenic infections 显示文摘 | Uluibau IC Jaunay T Goss AN | 2005 | Aust Dent J2005，50，42： | 1 |
| 16 | Polyparameter linear free energy relationships for estimating the equilibrium partition of organic compounds between water and the natural organic matter in soils and sediments 显示文摘 | Nguyen T H Goss K U Ball W P | 2005 | Environmental Science & Technology2005，39，4： | 1 |
| 17 | Wnt2/2b and 13 -Catenin signaling are necessary and sufficient to specify lung progenitors in the foregut显示文摘 | Goss AM Tian Y Tsukiyama T | 2009 | Dev Cell2009，17，2： | 1 |
| 18 | FdC1, a novel ferredoxin protein capable of alternative electron partitioning, increases in conditions of acceptor limitation at photosystem I 显示文摘 | VOSS I GOSS T MUROZUKA E | 2011 | JBiolChem2011，286，1： | 1 |
| 19 | Neural structures within the sheep tern- pore- mandibular joint 显示文摘 | Sarvestani T Raynmd A Goss A | 1996 | J Orofac Pain1996，10，3： | 1 |
| 20 | Double disruptions of the superior shoulder suspensory eomplex 显示文摘 | Goss T P | 1993 | J Orthop Trauma1993，7，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员